DK2074120T3 - Tropan-forbindelser - Google Patents
Tropan-forbindelserInfo
- Publication number
- DK2074120T3 DK2074120T3 DK08832769.7T DK08832769T DK2074120T3 DK 2074120 T3 DK2074120 T3 DK 2074120T3 DK 08832769 T DK08832769 T DK 08832769T DK 2074120 T3 DK2074120 T3 DK 2074120T3
- Authority
- DK
- Denmark
- Prior art keywords
- tropane compounds
- tropane
- compounds
- formula
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Molecular Biology (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Biotechnology (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Transplantation (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Gastroenterology & Hepatology (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68707P | 2007-10-25 | 2007-10-25 | |
PCT/US2008/012221 WO2009055077A1 (en) | 2007-10-25 | 2008-10-27 | Tropane compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2074120T3 true DK2074120T3 (da) | 2010-06-14 |
Family
ID=40287869
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK08832769.7T DK2074120T3 (da) | 2007-10-25 | 2008-10-27 | Tropan-forbindelser |
Country Status (27)
Country | Link |
---|---|
US (1) | US8012956B2 (da) |
EP (1) | EP2074120B1 (da) |
JP (2) | JP5476307B2 (da) |
KR (1) | KR101578792B1 (da) |
CN (1) | CN101910168B (da) |
AT (1) | ATE459622T1 (da) |
AU (1) | AU2008317262B2 (da) |
BR (1) | BRPI0818893B8 (da) |
CA (1) | CA2703477C (da) |
CO (1) | CO6321232A2 (da) |
CY (1) | CY1110648T1 (da) |
DE (1) | DE602008000754D1 (da) |
DK (1) | DK2074120T3 (da) |
EA (1) | EA018999B1 (da) |
ES (1) | ES2342348T3 (da) |
HK (1) | HK1129390A1 (da) |
HR (1) | HRP20100292T1 (da) |
IL (1) | IL205202A0 (da) |
MX (1) | MX2010004493A (da) |
NZ (1) | NZ585137A (da) |
PL (1) | PL2074120T3 (da) |
PT (1) | PT2074120E (da) |
RS (1) | RS51346B (da) |
SG (1) | SG2012079653A (da) |
SI (1) | SI2074120T1 (da) |
WO (1) | WO2009055077A1 (da) |
ZA (1) | ZA201002987B (da) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5650540B2 (ja) * | 2007-12-12 | 2015-01-07 | ライジェル ファーマシューティカルズ, インコーポレイテッド | 代謝障害のためのカルボキサミド、スルホンアミド、およびアミン化合物 |
FR2949467B1 (fr) | 2009-09-03 | 2011-11-25 | Sanofi Aventis | Nouveaux derives de 5,6,7,8-tetrahydroindolizine inhibiteurs d'hsp90, compositions les contenant et utilisation |
UY32940A (es) | 2009-10-27 | 2011-05-31 | Bayer Cropscience Ag | Amidas sustituidas con halogenoalquilo como insecticidas y acaricidas |
CA2795322A1 (en) | 2010-04-05 | 2011-10-13 | Shionogi & Co., Ltd. | Cephem compound having catechol group |
EP2640366A2 (en) | 2010-11-15 | 2013-09-25 | Exelixis, Inc. | Benzoxazepines as inhibitors of pi3k/mtor and methods of their use and manufacture |
EP2740474A1 (en) | 2012-12-05 | 2014-06-11 | Instituto Europeo di Oncologia S.r.l. | Cyclopropylamine derivatives useful as inhibitors of histone demethylases kdm1a |
WO2014107718A2 (en) * | 2013-01-07 | 2014-07-10 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Heat shock protein (hsp) inhibition and monitoring effectiveness thereof |
EA038819B1 (ru) | 2013-08-21 | 2021-10-25 | Алиос Биофарма, Инк. | Противовирусные соединения |
WO2015074025A1 (en) * | 2013-11-18 | 2015-05-21 | Del Mar Pharmaceuticals | Hplc analysis of impurities in dianhydrogalactitol |
AU2015265820C1 (en) | 2014-05-30 | 2020-01-16 | Ieo - Istituto Europeo Di Oncologia S.R.L. | Cyclopropylamine compounds as histone demethylase inhibitors |
EP2949648A1 (en) | 2014-05-30 | 2015-12-02 | IEO - Istituto Europeo di Oncologia Srl | Cyclopropylamine derivatives as histone demethylase inhibitors |
US20170224670A1 (en) | 2014-10-14 | 2017-08-10 | Exelixis, Inc. | Drug Combination to Treat Melanoma |
US20180200392A1 (en) * | 2015-07-16 | 2018-07-19 | Akuru Pharma Ab | Detection and treatment of renal cell carcinoma with a slc6a3 ligand linked to a label, cytotoxic or immunomodulatory group |
EP3588064B1 (en) * | 2017-02-23 | 2022-09-07 | IHI Corporation | Oh radical detection probe, oh radical measurement device, and oh radical measurement method |
CN108164529B (zh) * | 2017-12-25 | 2020-04-24 | 三峡大学 | 一种小分子抑制剂sld9059及其在制药中的应用 |
JP2021510699A (ja) | 2018-01-10 | 2021-04-30 | アリンキー バイオファーマAllinky Biopharma | テトラヒドロイソキノリン化合物 |
CN111825702A (zh) * | 2019-04-22 | 2020-10-27 | 成都科岭源医药技术有限公司 | 一种氮杂*并吲唑类衍生物及其制备方法和用途 |
CN110698395B (zh) * | 2019-10-22 | 2021-05-25 | 杭州百诚医药科技股份有限公司 | 一种托吡司特的中间体的制备方法 |
CN112920078A (zh) * | 2019-12-05 | 2021-06-08 | 武汉珈汇精化科技有限公司 | 一种制备4-氰基苯甲酸甲酯的方法和一种制备4-氰基苯甲酸的方法 |
TW202136238A (zh) * | 2020-01-06 | 2021-10-01 | 大陸商廣東東陽光藥業有限公司 | RORγt抑制劑及其製備方法和用途 |
KR20230088763A (ko) * | 2020-10-14 | 2023-06-20 | 라녹 테라퓨틱스 (항저우) 컴퍼니, 리미티드 | 표적 단백질 분해를 위한 방법 및 조성물 |
CN114591192B (zh) * | 2020-12-04 | 2024-06-21 | 江西仰立新材料有限公司 | 一种n-环丙甲基苯胺类化合物的制备方法 |
US20240083910A1 (en) * | 2020-12-18 | 2024-03-14 | Merck Sharp & Dohme Llc | Amido-substituted pyridyl compounds and methods of use thereof for the treatment of herpesviruses |
CN112707809B (zh) * | 2020-12-30 | 2023-08-29 | 丽珠集团新北江制药股份有限公司 | 一种制备噁唑啉杀虫剂氟雷拉纳中间体的方法 |
CN117729914A (zh) * | 2021-07-26 | 2024-03-19 | 硕腾服务有限责任公司 | 血清素5-ht2b抑制化合物 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0101641A3 (en) | 1982-07-22 | 1984-03-28 | Beecham Group Plc | Sulfonylamino-aza-bicyclo-alkyl derivatives |
FR2738569B1 (fr) * | 1995-09-12 | 1997-11-28 | Pf Medicament | Nouveaux derives naphtamide de 3 beta-amino azabicyclo octane ou nonane, leur procede de preparation, leur utilisation a titre de medicament antipsychotique |
MY117098A (en) | 1996-01-15 | 2004-05-31 | Janssen Pharmaceutica Nv | Angiogenesis inhibiting pyridazinamines |
HUP0202001A2 (hu) * | 2002-06-14 | 2005-08-29 | Sanofi-Aventis | DDP-IV gátló hatású azabiciklooktán- és nonánszármazékok |
ES2329133T3 (es) * | 2003-05-28 | 2009-11-23 | Theravance, Inc. | Compuestos azabicicloalcanicos como antagonistas de receptores de muscarinicos. |
KR20060030482A (ko) * | 2003-06-24 | 2006-04-10 | 뉴로서치 에이/에스 | 신규한 8-아자-바이사이클로[3.2.1]옥탄 유도체 및모노아민 신경전달물질 재흡수 억제제로서의 이의 용도 |
GB0323236D0 (en) * | 2003-10-03 | 2003-11-05 | Pfizer Ltd | Chemical compounds |
EP1682545B1 (en) * | 2003-10-03 | 2007-12-12 | Pfizer Limited | Imidazopyridine substituted tropane derivatives with ccr5 receptor antagonist activity for the treatment of hiv and inflammation |
ES2501240T3 (es) * | 2004-03-31 | 2014-10-01 | Nippon Soda Co., Ltd. | Compuesto de amina cíclica y agente de control de plagas |
FR2873693B1 (fr) * | 2004-07-29 | 2006-09-15 | Sanofi Synthelabo | Derives d'amino-tropane, leur preparation et leur application en therapeutique |
WO2006075004A2 (en) | 2005-01-13 | 2006-07-20 | Neurosearch A/S | 3, 8 - substituted 8-aza-bicyclo[3.2.1] octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
CN102127078A (zh) * | 2005-07-14 | 2011-07-20 | 安斯泰来制药株式会社 | Janus激酶3的杂环类抑制剂 |
KR101006362B1 (ko) * | 2005-10-06 | 2011-01-10 | 닛뽕소다 가부시키가이샤 | 고리형 아민 화합물 및 유해 생물 방제제 |
EP2050745B1 (en) * | 2006-09-01 | 2012-03-21 | Otsuka AgriTechno Co., Ltd | N-pyridylpiperidine compound, method for producing the same, and pest control agent |
-
2008
- 2008-10-27 BR BRPI0818893A patent/BRPI0818893B8/pt active IP Right Grant
- 2008-10-27 PT PT08832769T patent/PT2074120E/pt unknown
- 2008-10-27 AT AT08832769T patent/ATE459622T1/de active
- 2008-10-27 DE DE602008000754T patent/DE602008000754D1/de active Active
- 2008-10-27 SI SI200830024T patent/SI2074120T1/sl unknown
- 2008-10-27 EA EA201070519A patent/EA018999B1/ru not_active IP Right Cessation
- 2008-10-27 PL PL08832769T patent/PL2074120T3/pl unknown
- 2008-10-27 AU AU2008317262A patent/AU2008317262B2/en active Active
- 2008-10-27 US US12/290,159 patent/US8012956B2/en active Active
- 2008-10-27 MX MX2010004493A patent/MX2010004493A/es active IP Right Grant
- 2008-10-27 RS RSP-2010/0220A patent/RS51346B/en unknown
- 2008-10-27 JP JP2010531069A patent/JP5476307B2/ja active Active
- 2008-10-27 CN CN200880122860.5A patent/CN101910168B/zh active Active
- 2008-10-27 ES ES08832769T patent/ES2342348T3/es active Active
- 2008-10-27 KR KR1020107011444A patent/KR101578792B1/ko not_active Application Discontinuation
- 2008-10-27 NZ NZ585137A patent/NZ585137A/en unknown
- 2008-10-27 EP EP08832769A patent/EP2074120B1/en active Active
- 2008-10-27 DK DK08832769.7T patent/DK2074120T3/da active
- 2008-10-27 CA CA2703477A patent/CA2703477C/en active Active
- 2008-10-27 WO PCT/US2008/012221 patent/WO2009055077A1/en active Application Filing
- 2008-10-27 SG SG2012079653A patent/SG2012079653A/en unknown
-
2009
- 2009-10-09 HK HK09109388.2A patent/HK1129390A1/xx unknown
-
2010
- 2010-04-19 IL IL205202A patent/IL205202A0/en active IP Right Grant
- 2010-04-29 ZA ZA2010/02987A patent/ZA201002987B/en unknown
- 2010-05-24 CO CO10061824A patent/CO6321232A2/es not_active Application Discontinuation
- 2010-05-24 HR HR20100292T patent/HRP20100292T1/hr unknown
- 2010-06-01 CY CY20101100483T patent/CY1110648T1/el unknown
-
2013
- 2013-12-13 JP JP2013257559A patent/JP5745021B2/ja active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2074120T3 (da) | Tropan-forbindelser | |
EA201100037A1 (ru) | Органические соединения | |
CY1118199T1 (el) | Ενωσεις υποκατεστημενης πυραζολο[1,5] πυριμιδινης ως ενδιαμεσα στη συνθεση αναστολεων κινασης trk | |
EA201270254A1 (ru) | Производные 5-фторпиримидинона | |
EA201070786A1 (ru) | Бензофуропиримидиноны | |
UA107445C2 (uk) | 5-фторпіримідинові похідні як фунгіциди | |
SMP201100019B (it) | Composti organici | |
EA201201377A1 (ru) | Определенные аминопиридазины, композиции на их основе и способы их использования | |
BR112012018345A2 (pt) | "compostos de heteroarila, bem como composições e usos dos mesmos" | |
MA32383B1 (fr) | DÉRIVÉS D'INDAZOLES à SUBSTITUTIONS PHÉNYLE ET BENZODIOXYNYLE | |
WO2010003133A3 (en) | Cdk modulators | |
RS53301B (en) | TIOACETATE COMPOUNDS, COMPOSITIONS AND USE PROCEDURES | |
EA201270257A1 (ru) | Производные n1-сульфонил-5-фторпиримидинона | |
UA108101C2 (xx) | Похідні n3-заміщених n1-сульфоніл-5-фторпіримідинонів | |
EA201170884A1 (ru) | Производные пиперидина, пригодные в качестве антагонистов орексина | |
PH12012501905A1 (en) | Quinoline derivatives and their use as fungicides | |
NO20085317L (no) | Imidazoazepinonforbindelser | |
UA106889C2 (uk) | Похідні n1-ацил-5-фторпіримідинону | |
ATE481395T1 (de) | Cyclohexylderivate | |
ATE533477T1 (de) | Pharmazeutische zusammensetzungen enthaltend irbesartan | |
RS53747B1 (en) | FENANTRENON UNITS, COMPOSITIONS AND METHODS | |
UY30235A1 (es) | Inhibidores de la adenilato ciclasa soluble | |
NZ590367A (en) | 9-Substituted-5-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials | |
EA200702590A1 (ru) | Ингибиторы растворимой аденилатциклазы | |
UY30237A1 (es) | Inhibidores de la adenilato ciclasa soluble |